×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| PFIZER LTD. | 6702.2 | 1917.5 | 6030.5 | 41.91 | 23,444 | 153.0 |
| Eris Lifesciences Limited | 6013.2 | 999.9 | 5786.4 | 7.33 | 23312 | 60.2 |
| ASTRAZENECA PHARMA INDIA LTD. | 5375.5 | 558.3 | 5263.1 | 22.33 | 22500 | 106.0 |
Pfizer Ltd.,, with Security Code 500680, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 572.6 | 531.4 | 575.2 | 540.0 | 546.6 | 562.9 | 588.6 | 538.0 | 591.9 | 603.1 |
| Expenses | 390.8 | 420.7 | 392.6 | 387.4 | 357.2 | 385.4 | 399.3 | 392.0 | 364.4 | 393.0 |
| Operating Profit | 181.9 | 110.7 | 182.6 | 152.6 | 189.4 | 177.5 | 189.3 | 146.0 | 227.5 | 210.0 |
| OPM % | 31.76% | 20.84% | 31.75% | 28.25% | 34.65% | 31.53% | 32.15% | 27.14% | 38.43% | 34.83% |
| Other Income | 11.8 | 33.5 | 36.1 | 43.8 | 75.1 | 41.8 | 43.1 | 42.8 | 217.4 | 67.2 |
| Interest | 2.5 | 2.9 | 2.7 | 2.9 | 7.0 | 2.1 | 2.1 | 1.5 | 2.7 | 3.3 |
| Depreciation | 26.4 | 15.6 | 15.4 | 17.6 | 13.8 | 14.6 | 15.0 | 14.8 | 16.4 | 14.4 |
| Profit before tax | 184.3 | 125.8 | 200.5 | 168.0 | 243.9 | 202.6 | 215.2 | 172.4 | 253.0 | 259.5 |
| Tax % | -21.3% | -25.6% | -25.7% | -26.1% | -26.7% | 25.6% | 26.4% | 26% | -22.3% | 26.1% |
| Net Profit | 129.7 | 93.5 | 149.0 | 130.0 | 178.9 | 150.7 | 158.4 | 127.6 | 330.9 | 191.8 |
| EPS in Rs | 28.34 | 20.44 | 32.56 | 27.12 | 22.33 | 32.94 | 0 | 27.89 | 0 | 41.91 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 1% |
| 3 Years: | -4% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| 1 Year: | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| 1 Year: | 12% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|